Adma Biologics (ADMA) Return on Invested Capital (2011 - 2025)
Adma Biologics (ADMA) reported Return on Invested Capital of 0.0% for Q4 2025, little changed on a YoY basis from 0.0% in Q4 2024, and down 37.56% quarter-over-quarter from 0.01% in Q3 2025.
Adma Biologics (ADMA) Return on Invested Capital (2011 - 2025) Analysis & Trends
Adma Biologics has reported Return on Invested Capital for 4 years, with the latest figure at 0.0% in Q4 2025.
- For the quarter ending Q4 2025, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Dec 2025 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, down 1.0% from the prior year.
- Return on Invested Capital for Q4 2025 stood at 0.0%, down from 0.01% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.01% in Q4 2024, with the low at 0.0% in Q1 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.01% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -0.01% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -0.01% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Adma Biologics | 1.98 Bn | 1.89 Bn | 88.82 Mn | 0.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.01% |
| Jun 30, 2025 | 0.01% |
| Mar 31, 2025 | 0.01% |
| Dec 31, 2024 | 0.01% |
| Sep 30, 2024 | 0.01% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2012 | -0.01% |
| Sep 30, 2012 | 0.00% |
| Jun 30, 2012 | 0.00% |
| Mar 31, 2012 | 0.00% |
| Dec 31, 2011 | -0.23% |